You are here
Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
Sten MadsbadJournal of Diabetes and its Complications, Volume 30, Issue 2, March 2016, Pages 374–385
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial
Tim Heise, Eric Zijlstra, Leszek Nosek, Tord Rikte, Hanne HaahrDiabetes, Obesity and Metabolism 2017; 19(2):208–215
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Tim Heise, Ulrike Hövelmann, Eric Zijlstra, Kirstine Stender-Petersen, Jacob Bonde Jacobsen, Hanne HaahrDrugs Aging (2017) 34: 29. doi:10.1007/s40266-016-0418-6